Инновационные методы терапии эндометриоза: оценка эффективности мицеллярного куркумина на основании экспериментальной хирургически‑индуцированной модели заболевания

1. Министерство здравоохранения Российской Федерации. Проект клинических рекомендаций. Эндометриоз. 2024.
2. Becker C.M., Bokor A., Heikinheimo O., Horne A., Jansen F., Kiesel L. et al. ESHRE guideline: endometriosis. Hum. Reprod. Open. 2022; 2022(2): hoac009. https://dx.doi.org/10.1093/hropen/hoac009.
3. Ярмолинская М.И., Хачатурян А.Р., Андреева Н.Ю., Пьянкова В.О. Современные возможности и перспективы применения пероральной формы антагонистов гонадотропин-рилизинг-гормона (обзор литературы). Проблемы репродукции. 2020; 26(5): 78-83.
4. Ярмолинская М.И., Абашова Е.И., Мишарина Е.В., Хачатурян А.Р., Шалина М.А., Мусина Е.В., Молотков А.С., Флорова М.С., Денисова А.С., Суслова Е.В., Андреева Н.Ю., Дурнева Е.И., Тхазаплижева С.Ш., Хобец В.В., Нетреба Е.А. Медикаментозная терапия генитального эндометриоза: реалии и перспективы. М.: ООО "ГЭОТАР-Медиа"; 2021. 384 с.
5. Maiorana A., Maranto M., Restivo V., Gerfo D.L., Minneci G., Mercurio A. et al. Evaluation of long-term efficacy and safety of dienogest in patients with chronic cyclic pelvic pain associated with endometriosis. Arch. Gynecol. Obstet. 2024; 309(2): 589-97. https://dx.doi.org/10.1007/s00404-023-07271-7.
6. Сухих Г.Т., Адамян Л.В., Козаченко А.В., Дубровина С.О., Баранов И.И., Радзинский В.Е. и др. Дидрогестерон для лечения подтвержденного эндометриоза: ключевые результаты наблюдательного открытого многоцентрового исследования в условиях реальной клинической практики (исследование Орхидея). Акушерство и гинекология: новости, мнения, обучение. 2020; 8(4): 79-81.
7. Deng T., Lin Y., Chen L., Jiang J.Y. Comparison of dydrogesterone and GnRH-a effects after laparoscopic surgery in patients with stage III and IV endometriosis. Int. J. Gen. Med. 2023; 16: 4357-64. https://dx.doi.org/10.2147/IJGM.S429953.
8. Lee N., Min S., Won S., Cho Y.J., Kim M., Kim M.K. et al. The recurrence rate of ovarian endometrioma in women aged 40-49 years and impact of hormonal treatment after conservative surgery. Sci. Rep. 2020; 10(1): 16461. https://dx.doi.org/10.1038/s41598-020-73434-0.
9. D’Alessandro G., Barra F., Tantari M., Ferrero S. Hormonal treatments for preventing recurrence of endometriomas. Gynecology and Pelvic Medicine. 2020; 3: 20. https://dx.doi.org/10.21037/gpm-20-23.
10. Nodler J.L., DiVasta A.D., Vitonis A.F., Karevicius S., Malsch M., Sarda V. et al. Supplementation with vitamin D or omega-3 fatty acids in adolescent girls and young women with endometriosis (SAGE): a double-blind, randomized, placebo-controlled trial. Am. J. Clin. Nutr. 2020; 112(1): 229-36. https://dx.doi.org/10.1093/ajcn/nqaa096.
11. Rashidi N., Arefi S., Sadri M., Delbandi А.А. Effect of active vitamin D on proliferation, cell cycle and apoptosis in endometriotic stromal cells. Reprod. Biomed. Online. 2023; 46(3): 436-45. https://dx.doi.org/10.1016/j.rbmo.2022.11.009.
12. Ярмолинская М.И., Шалина М.А., Беганова А.К., Сейидова Ч.И. Перспективы сочетанного применения транс-ресвератрола и индол-3-карбинола при эндометриозе. Акушерство и гинекология. 2022; 4: 14-24.
13. Zhang L., Mohankumar K., Martin G., Mariyam F., Park Y., Han S.J. et al. Flavonoids quercetin and kaempferol are NR4A1 antagonists and suppress endometriosis in female mice. Endocrinology. 2023; 164(10): bqad133. https://dx.doi.org/10.1210/endocr/bqad133.
14. Lu H., Hu H., Yang Y., Li S. The inhibition of reactive oxygen species (ROS) by antioxidants inhibits the release of an autophagy marker in ectopic endometrial cells. Taiwan J. Obstet. Gynecol. 2020; 59(2): 256-61. https://dx.doi.org/10.1016/j.tjog.2020.01.014.
15. Ярмолинская М.И., Сейидова Ч.И., Траль Т.Г. Способ лечения эндометриоза у крыс в эксперименте. Патент на изобретение RU 2816983 С1. 2024.
16. Zhong Y., Tu Y., Ma Q., Chen L., Zhang W., Lu X. et al. Curcumin alleviates experimental colitis in mice by suppressing necroptosis of intestinal epithelial cells. Front. Pharmacol. 2023; 14: 1170637. https://dx.doi.org/10.3389/fphar.2023.1170637.
17. Xu Z., Shang W., Zhao Z., Zhang B., Liu C., Cai H. Curcumin alleviates rheumatoid arthritis progression through the phosphatidylinositol 3-kinase/protein kinase B pathway: an in vitro and in vivo study. Bioengineered. 2022; 13(5): 12899-911. https://dx.doi.org/10.1080/21655979.2022.2078942.
18. Li X., Fang Q., Tian X., Wang, X., Ao Q., Hou W. et al. Curcumin attenuates the development of thoracic aortic aneurysm by inhibiting VEGF expression and inflammation. Mol. Med. Rep. 2017; 16(4): 4455-62. https://dx.doi.org/10.3892/mmr.2017.7169.
19. Yao B., Xin Z.K., Wang D. The effect of curcumin on on intravitreal proinflammatory cytokines, oxidative stress markers, and vascular endothelial growth factor in an experimental model of diabetic retinopathy. J. Physiol. Pharmacol. 2023; 74(6). https://dx.doi.org/10.26402/jpp.2023.6.07.
20. Liu M., Zhou X., Wang X.J., Wang Y.S., Yang S.J., Ding Z.M. et al. Curcumin alleviates bisphenol AF-induced oxidative stress and apoptosis in caprine endometrial epithelial cells via the Nrf2 signaling pathway. Environ. Toxicol. 2023; 38(12): 2904-14. https://dx.doi.org/10.1002/tox.23925.
21. Wei H., Li X., Liu F., Li Y., Luo B., Huang X. et al. Curcumin inhibits the development of colorectal cancer via regulating the USP4/LAMP3 pathway. Naunyn Schmiedebergs Arch. Pharmacol. 2024; 397(3): 1749-62. https://dx.doi.org/10.1007/s00210-023-02721-0.
22. Muneesa M. F., Barki R.R., Shaikh S.B., Bhandary Y.P. Curcumin intervention during progressive fibrosis controls inflammatory cytokines and the fibrinolytic system in pulmonary fibrosis. Toxicol. Appl. Pharmacol. 2022; 449: 116116. https://dx.doi.org/10.1016/j.taap.2022.116116.
23. Dehzad M.J., Ghalandari H., Amini M.R., Askarpour M. Effects of curcumin/turmeric supplementation on lipid profile: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials. Complement Ther. Med. 2023; 75: 102955. https://dx.doi.org/10.1016/j.ctim.2023.102955.
24. Abadi A.J., Mirzaei S., Mahabady M.K, Hashemi, F., Zabolian A., Hashemi F. et al. Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects. Phytother. Res. 2022; 36(1): 189-213. https://dx.doi.org/10.1002/ptr.7305.
25. Li N., Liu T.H., Yu J.Z., Li C. X., Liu Y., Wu Y.Y. et al. Curcumin and curcumol inhibit NF-kappaB and TGF-beta (1)/Smads signaling pathways in CSE-treated RAW246.7 cells. Evid. Based Complement Alternat. Med. 2019; 2019: 3035125. https://dx.doi.org/10.1155/2019/3035125.
26. Haryuna T.S.H., Fauziah D., Anggraini S., Harahap M.P.H., Harahap J. Antioxidant effect of curcumin on the prevention of oxidative damage to the cochlea in an ototoxic rat model based on malondialdehyde expression. Int. Arch. Otorhinolaryngol. 2022; 26(1): e119-e124. https://dx.doi.org/10.1055/s-0040-1722161.
27. Guan T., Ding L.G., Lu B.Y., Guo J.Y., Wu M.Y., Tan Z.Q. et al. Combined administration of curcumin and chondroitin sulfate alleviates cartilage injury and inflammation via NF-kappaB pathway in knee osteoarthritis rats. Front. Pharmacol. 2022; 13: 882304. https://dx.doi.org/10.3389/fphar.2022.882304.
28. Zhang Y., Cao H., Hu Y.Y., Wang H., Zhang C.J. Inhibitory effect of curcumin on angiogenesis in ectopic endometrium of rats with experimental endometriosis. Int. J. Mol. Med. 2011; 27(1): 87-94. https://dx.doi.org/10.3892/ijmm.2010.552.
29. Kuo C.N., Chen C.H., Chen S.N., Huang, J.C., Lai L.J., Lai C.H. et al. Anti-angiogenic effect of hexahydrocurcumin in rat corneal neovascularization. Int. Ophthalmol. 2018; 38(2): 747-56. https://dx.doi.org/10.1007/s10792-017-0530-6.
30. Afshari H., Noori S., Zarghi A. Curcumin potentiates the anti-inflammatory effects of Tehranolide by modulating the STAT3/NF-kappaB signaling pathway in breast and ovarian cancer cell lines. Inflammopharmacology. 2023; 31(5): 2541-55. https://dx.doi.org/10.1007/s10787-023-01281-2.
31. Mukherjee D., Krishnan A. Therapeutic potential of curcumin and its nanoformulations for treating oral cancer. World J. Methodol. 2023; 13(3): 29-45. https://dx.doi.org/10.5662/wjm.v13.i3.29.
32. Afrasiabi S., Partoazar A., Chiniforush N. In vitro study of nanoliposomes containing curcumin and doxycycline for enhanced antimicrobial photodynamic therapy against Aggregatibacter actinomycetemcomitans. Sci. Rep. 2023; 13(1):11552. https://dx.doi.org/10.1038/s41598-023-38812-4.
33. Jamwal R. Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers. J. Integr. Med. 2018; 16(6): 367-74. https://dx.doi.org/10.1016/j.joim.2018.07.001.
34. Kurihara C., Kerpel-Fronius S., Becker S., Chan, A., Nagaty Y., Naseem S. et al. Declaration of Helsinki: ethical norm in pursuit of common global goals. Front. Med. (Lausanne). 2024; 11: 1360653. https://dx.doi.org/10.3389/fmed.2024.1360653.
35. Ярмолинская М.И., Петросян М.А., Флорова М.С., Молотков А.С., Денисова А.С., Суслова Е.В., Тхазаплижева С.Ш. Сравнительная оценка эффективности перспективных препаратов для таргетной терапии эндометриоза на основании экспериментальной модели заболевания. Гинекология. 2018; 20(5): 46-51.
36. Swarnakar S., Paul S. Curcumin arrests endometriosis by downregulation of matrix metalloproteinase-9 activity. Indian J. Biochem. Biophys. 2009; 46(1): 59-65.
37. Jana S., Paul S., Swarnakar S. Curcumin as anti-endometriotic agent: implication of MMP-3 and intrinsic apoptotic pathway. Biochem. Pharmacol. 2012; 83(6): 797-804. https://dx.doi.org/10.1016/j.bcp.2011.12.030.
38. Ding J., Mei S., Cheng W., Ni Z., Yu C. Curcumin treats endometriosis in mice by the HIF signaling pathway. Am. J. Transl. Res. 2022; 14(4): 2184-98.
39. Boroumand S., Hosseini S., Pashandi Z., Faridi-Majidi R., Salehi M. Curcumin-loaded nanofibers for targeting endometriosis in the peritoneum of a mouse model. J. Mater. Sci. Mater. Med. 2019; 31(1): 8. https://dx.doi.org/10.1007/s10856-019-6337-4.
40. Kizilay G., Uz Y.H., Seren G., Ulucam E., Yilmaz A., Cukur Z. et al. In vivo effects of curcumin and deferoxamine in experimental endometriosis. Adv. Clin. Exp. Med. 2017; 26(2): 207-13. https://dx.doi.org/10.17219/acem/31186.

Поступила 22.08.2024

Принята в печать 13.09.2024